Clinical Peptidomics in Acute Leukemias: Current Advances and Future Perspectives

J Proteome Res. 2024 Dec 6;23(12):5263-5273. doi: 10.1021/acs.jproteome.4c00807. Epub 2024 Nov 18.

Abstract

The study of circulating peptides in the blood offers significant opportunities for diagnosing, stratifying, and managing various diseases. With recent technological advances and the ongoing need to understand complex diseases such as acute leukemias (AL), peptidomic analysis of peripheral blood, especially serum and plasma, has become increasingly important for studying human biology and pathophysiology. Here, we provide insights and perspectives on technological developments and potential clinical applications using widely used peptidomic analysis methods. We discuss examples where peptidomics using serum or plasma has contributed to the understanding of AL. Specifically, we highlight the scarcity of peptidomic studies applied to AL and emphasize the importance of exploring this area, as the few published studies present promising results that can significantly contribute to precision medicine.

Keywords: Acute Leukemias; Blood Biomarkers; Clinical Peptidomics.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Biomarkers, Tumor / blood
  • Humans
  • Leukemia* / blood
  • Leukemia* / diagnosis
  • Peptides / analysis
  • Peptides / blood
  • Precision Medicine / methods
  • Proteomics* / methods

Substances

  • Peptides
  • Biomarkers, Tumor